154 related articles for article (PubMed ID: 32606095)
21. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
Swanson M; Ibrahim S; Blat C; Oketch S; Olwanda E; Maloba M; Huchko MJ
BMC Womens Health; 2018 Jul; 18(1):116. PubMed ID: 29970063
[TBL] [Abstract][Full Text] [Related]
22. Mobile Phone Ownership and Use Among Women Screening for Cervical Cancer in a Community-Based Setting in Western Kenya: Observational Study.
Stocks J; Ibrahim S; Park L; Huchko M
JMIR Public Health Surveill; 2022 Jun; 8(6):e28885. PubMed ID: 35671089
[TBL] [Abstract][Full Text] [Related]
23. Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China's largest independent operator of pathology laboratories.
Xie F; Zhang L; Zhao D; Wu X; Wei M; Zhang X; Wu X; Fang H; Xu X; Yang M; Qi D
BMC Infect Dis; 2019 Nov; 19(1):962. PubMed ID: 31711435
[TBL] [Abstract][Full Text] [Related]
24. Cervical cancer screening in sub-Saharan Africa: a randomized trial of VIA versus cytology for triage of HPV-positive women.
Bigoni J; Gundar M; Tebeu PM; Bongoe A; Schäfer S; Fokom-Domgue J; Catarino R; Tincho EF; Bougel S; Vassilakos P; Petignat P
Int J Cancer; 2015 Jul; 137(1):127-34. PubMed ID: 25420434
[TBL] [Abstract][Full Text] [Related]
25. Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis.
Gottschlich A; Rivera-Andrade A; Bevilacqua K; Murchland AR; Isak E; Alvarez CS; Ogilvie G; Carey TE; Prince M; Dean M; Mendoza-Montano C; Meza R
BMC Public Health; 2020 Sep; 20(1):1406. PubMed ID: 32933512
[TBL] [Abstract][Full Text] [Related]
26. Age patterns of human papillomavirus infection as primary screening test for cervical cancer and subsequent triage with visual inspection in Honduras.
Sandoval M; Holme F; Lobo S; Slavkovsky R; Thomson KA; Jeronimo J; Figueroa J; Sanjose S
Salud Publica Mex; 2020; 62(5):487-493. PubMed ID: 32697901
[TBL] [Abstract][Full Text] [Related]
27. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of multiple primary and combination screening strategies in postmenopausal women for detection of cervical cancer in China.
Holt HK; Zhang L; Zhao FH; Hu SY; Zhao XL; Zhang X; Pan QJ; Zhang WH; Smith JS; Qiao YL
Int J Cancer; 2017 Feb; 140(3):544-554. PubMed ID: 27727464
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and Associated Factors of Abnormal Cervical Cytology and HighRisk HPV DNA among Bangkok Metropolitan Women.
Tangjitgamol S; Kantathavorn N; Kittisiam T; Chaowawanit W; Phoolcharoen N; Manusirivithaya S; Khunnarong J; Srijaipracharoen S; Saeloo S; Krongthong W; Supawattanabodee B; Thavaramara T; Pataradool K
Asian Pac J Cancer Prev; 2016; 17(7):3147-53. PubMed ID: 27509943
[TBL] [Abstract][Full Text] [Related]
30. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
31. Results of a Pilot Study of a Mail-Based Human Papillomavirus Self-Testing Program for Underscreened Women From Appalachian Ohio.
Reiter PL; Shoben AB; McDonough D; Ruffin MT; Steinau M; Unger ER; Paskett ED; Katz ML
Sex Transm Dis; 2019 Mar; 46(3):185-190. PubMed ID: 30461597
[TBL] [Abstract][Full Text] [Related]
32. A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program.
Kellen E; Benoy I; Vanden Broeck D; Martens P; Bogers JP; Haelens A; Van Limbergen E
Int J Cancer; 2018 Aug; 143(4):861-868. PubMed ID: 29569715
[TBL] [Abstract][Full Text] [Related]
33. Comparative assessment of test characteristics of cervical cancer screening methods for implementation in low-resource settings.
Asgary R; Beideck E; Naderi R
Prev Med; 2022 Jan; 154():106883. PubMed ID: 34785209
[TBL] [Abstract][Full Text] [Related]
34. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
Othman N; Othman NH
Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer: implementation studies from five sub-Saharan African countries.
Joseph J; Demke O; Ameyan L; Bitilinyu-Bango J; Bourgoin B; Diop M; Guèye B; Kama J; Lubega M; Madzima B; Maparo T; Mhizha T; Musoke A; Nabadda S; Phiri T; Tchereni T; Wiwa O; Hariharan K; Peter T; Khan S
BMJ Open; 2023 Jan; 13(1):e065074. PubMed ID: 36609331
[TBL] [Abstract][Full Text] [Related]
36. Health Outcomes at 1 Year After Thermal Ablation for Cervical Precancer Among Human Papillomavirus- and Visual Inspection With Acetic Acid-Positive Women in Honduras.
Slavkovsky RC; Bansil P; Sandoval MA; Figueroa J; Rodriguez DM; Lobo JS; Jeronimo JA; de Sanjosé S
JCO Glob Oncol; 2020 Oct; 6():1565-1573. PubMed ID: 33074738
[TBL] [Abstract][Full Text] [Related]
37. Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study.
Kwan TT; Cheung AN; Lo SS; Lee PW; Tam KF; Chan KK; Ngan HY
Acta Obstet Gynecol Scand; 2011 May; 90(5):445-51. PubMed ID: 21306349
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and determinants of cervical cancer screening with a combination of cytology and human papillomavirus testing.
Fokom Domgue J; Cunningham SA; Yu RK; Shete S
Ann Epidemiol; 2019 Aug; 36():40-47. PubMed ID: 31320153
[TBL] [Abstract][Full Text] [Related]
39. Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial.
Arrossi S; Thouyaret L; Herrero R; Campanera A; Magdaleno A; Cuberli M; Barletta P; Laudi R; Orellana L;
Lancet Glob Health; 2015 Feb; 3(2):e85-94. PubMed ID: 25617202
[TBL] [Abstract][Full Text] [Related]
40. Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014.
Wright JD; Chen L; Tergas AI; Melamed A; St Clair CM; Hou JY; Khoury-Collado F; Gockley A; Accordino M; Hershman DL
JAMA Netw Open; 2021 Apr; 4(4):e218373. PubMed ID: 33914050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
